The Royal Womens Hospital

Parkville 3052

1 studies enrolling now · 4 studies all time

What they study most

Advanced Ovarian Cancer, BRCA Mutated, BRCA Mutation, Complete Response, Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN), Erythroblastosis, Fetal, FIGO Stage III-IV, First Line Platinum Chemotherapy, Following Complete or Partial Response to Platinum Based Chemotherapy, Hemolytic Disease of the Fetus and Newborn, Newly Diagnosed, Partial Response

Studies at this site

• A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry — Recruiting now
• Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy — Running, not enrolling
• Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. — Running, not enrolling
• A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn — Completed